ERLEVA 100MG TAB

ERLEVA 100MG TAB is a prescription medication used to treat certain types of cancer, including:

• Non-small cell lung cancer (NSCLC)
• Pancreatic cancer

Composition:

Each tablet of ERLEVA 100MG TAB contains 150mg of erlotinib.

Mechanism of Action:

Erlotinib works by:

• Inhibiting the action of epidermal growth factor receptor (EGFR), a protein that helps regulate cell growth and division
• Blocking the signaling pathways that allow cancer cells to grow and multiply
• Causing cancer cells to die or stop growing

Uses:

ERLEVA 100MG TAB is used to treat:

• NSCLC that has progressed or recurred after previous treatment
• Pancreatic cancer in combination with gemcitabine (Gemzar) in patients who have not received prior chemotherapy

Dosage:

The recommended dosage of ERLEVA 100MG TAB is:

• 150mg taken orally once daily, in combination with gemcitabine (Gemzar) for pancreatic cancer
• 150mg taken orally once daily, as a single agent for NSCLC

Side Effects:

Common side effects of ERLEVA 100MG TAB include:

• Rash
• Diarrhea
• Fatigue
• Nausea and vomiting
• Anorexia
• Skin toxicity
• Increased risk of infections

Recommendation:

ERLEVA 100MG TAB is recommended for patients who have not responded to previous treatment for their cancer. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take ERLEVA 100MG TAB if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking ERLEVA 100MG TAB.

Some common brands of erlotinib include:

• Tarceva (Roche)
• Erlonat (Astellas)

Please note that ERLEVA 100MG TAB is not available in all markets and may be approved for different indications and dosages in different regions.

It’s worth noting that ERLEVA 100MG TAB is a targeted therapy, meaning it is designed to specifically target the EGFR pathway in cancer cells. This can be an effective treatment option for patients with certain types of cancer, as it can help to slow or stop the growth of cancer cells.